Megalencephalic leucoencephalopathy with subcortical cysts: subcortical diffuse leucoencephalopathy associated with...

Area of Science:

• Neuroscience
• Genetics
• Pediatric Neurology

Background:

• Megalencephalic leucoencephalopathy with subcortical cysts (MLC) is a rare genetic disorder characterized by diffuse white matter degeneration and subcortical cysts.
• It is caused by mutations in the MLC1 gene, leading to neurological abnormalities including macrocephaly, motor deterioration, ataxia, spasticity, and cognitive deficits.
• Current management focuses on supportive care, including physiotherapy, psychomotor stimulation, and seizure management, as no specific treatment exists.

Observation:

• A 1-year-old boy with a normal birth and developmental history presented with a progressively increasing head size.
• Clinical evaluation revealed macrocephaly, a key early sign of MLC.
• Brain imaging, including CT and MRI, confirmed diffuse leucoencephalopathy with cystic degeneration, consistent with MLC.

Findings:

• The patient's presentation of macrocephaly and subsequent neurological symptoms aligned with the typical progression of Megalencephalic leucoencephalopathy with subcortical cysts.
• Genetic analysis, while not detailed in the abstract, is the established method for confirming MLC diagnosis due to mutations in the MLC1 gene.
• The diagnostic process involved correlating clinical signs with neuroimaging findings.

Implications:

• This case underscores the importance of recognizing macrocephaly as an early indicator of potential underlying neurological disorders like MLC in infants.
• Early diagnosis of MLC is crucial for initiating timely supportive and symptomatic management, potentially improving patient outcomes.
• Further research into the genetic basis and potential therapeutic targets for MLC is warranted to develop effective treatments for this debilitating condition.